DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Friday, 17 April 2015

Development of a simple and stability-indicating RP-HPLC method for determining olanzapine and related impurities generated in the preparative process


Displaying image.png

Development of a simple and stability-indicating RP-HPLC method for determining olanzapine and related impurities generated in the preparative process

Daoping Cui,a   Yueqing Li,a   Mingming Lian,a   Feng Yangb and  Qingwei Meng*a  

*
Corresponding authors
a
State Key Laboratory of Fine Chemicals, School of Pharmaceutical Science and Technology, Dalian University of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian, P. R. China
E-mail: mengqw@dlut.edu.cn
b
Merro Pharmaceutical Companies, No. 9 Yingsheng Road, Ganjingzi District, Dalian, P. R. China
Analyst, 2011,136, 3149-3156

DOI: 10.1039/C1AN15155Jhttp://pubs.rsc.org/en/content/articlelanding/2011/an/c1an15155j#!divAbstract




























A simple and stability-indicating reverse phase high performance liquid chromatographic (RP-HPLC) method was developed and validated for the determination of olanzapine (OLN) and related impurities in bulk drugs. Eight impurities were characterized respectively, and particularly a new process impurity from OLN synthesis was structurally confirmed as 1-(5-methylthionphen-2-yl)-1H-benzimidazol-2(3H)-one (Imp-7) by X-ray single crystal diffraction,MS1H NMR13C NMR and HSQC. A mechanism of formation pathway for Imp-7 was proposed. Optimum separation for OLN and eight related impurities was carried out on an Agilent Octyldecyl silica column (TC-C18, 4.6 mm × 250 mm, 5 μm) using a gradient HPLC method. The method was validated with respect to specificity, linearity, accuracy, precision, LOD and LOQ. Regression analysis showed good correlation (r2 > 0.9985) between the investigated component concentrations and their peak areas within the test ranges for OLN and eight impurities. The repeatability and intermediate precision, expressed as RSD, were less than 1.74%. The proposed stability-indicating method was suitable for routine quality control anddrug analysis of OLN in bulk drugs.


Graphical abstract: Development of a simple and stability-indicating RP-HPLC method for determining olanzapine and related impurities generated in the preparative process























............

Displaying image.png


Displaying image.png

a State Key Laboratory of Fine Chemicals, School of Pharmaceutical Science and Technology, Dalian University of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian, Liaoning Province, 116024, P. R. China. E-mail: mengqw@dlut.edu.cn














b Merro Pharmaceutical Companies, No. 9 Yingsheng Road, Ganjingzi District, Dalian, Liaoning Province, 116036, P. R. China















P.S. : The views expressed are my personal and in no-way suggest the views of the professional body or the company that I represent.
P.S. : The views expressed are my personal and in no-way suggest the views of the professional body or the company that I represent.
P.S. : The views expressed are my personal and in no-way suggest the views of the professional body or the company that I represent.




COCK WILL TEACH YOU NMR
COCK SAYS MOM CAN TEACH YOU NMR
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO …..FOR BLOG HOME CLICK HERE
Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK
Join me on twitterFollow amcrasto on Twitter
Join me on google plus Googleplus

 amcrasto@gmail.com



No comments:

Post a Comment